Literature DB >> 8537547

In vitro comparative study of the antitumor effects of human interferon-alpha, beta and gamma on the growth and invasive potential of human melanoma cells.

T Horikoshi1, K Fukuzawa, N Hanada, K Ezoe, H Eguchi, S Hamaoka, H Tsujiya, T Tsukamoto.   

Abstract

We have studied the effects of interferon (IFN)-alpha, beta, and gamma in vitro on the growth and invasive potential of human melanoma SK-MEL-118 cells. The antiproliferative effects of IFNs were assessed by a quantitative regrowth assay in which cells were treated with IFNs at concentrations of 10(2), 10(3) or 10(4) IU/ml for 3 days (until day 4) and then further incubated without IFNs for 7 days (until day 11). The growth inhibitory effect of each IFN on melanoma cells was dose- and time-dependent. Among these three types of IFNs, however, IFN-beta exerted the strongest inhibitory effect on cell growth. To assess the anti-invasive effect of each IFN on melanoma cells, we employed an in vitro assay system using matrigel-coated Transwell chambers. When cells were treated with 10(2), 10(3), or 10(4) IU/ml of the three types of IFNs for 24 hours, the amount of tritiated thymidine incorporated into melanoma cells were treated for 24 hours with 10(4) IU/ml of IFN-beta or gamma prior to the assay, the number of cells that invaded the filter decreased by 40%; this decrease was only 10% with the same amount of IFN-alpha. Simultaneous addition of IFNs during the invasion assay was not effective in any combination. Only when the cells were pretreated with IFNs, antiinvasive effects against melanoma cells were exerted. IFN-alpha was less inhibitory than IFN-beta or gamma on proliferation and not at all inhibitory on invasion. Considering both the antiproliferative and antiinvasive effects of IFNs, our results suggest that IFN-beta has the strongest antitumoral effect on human melanoma cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537547     DOI: 10.1111/j.1346-8138.1995.tb03889.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  6 in total

1.  Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response.

Authors:  C Rozera; D Carlei; P L Lollini; C De Giovanni; P Musiani; E Di Carlo; F Belardelli; M Ferrantini
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

2.  Autophagy mediated by arginine depletion activation of the nutrient sensor GCN2 contributes to interferon-γ-induced malignant transformation of primary bovine mammary epithelial cells.

Authors:  X-J Xia; Y-Y Gao; J Zhang; L Wang; S Zhao; Y-Y Che; C-J Ao; H-J Yang; J-Q Wang; L-C Lei
Journal:  Cell Death Discov       Date:  2016-01-25

3.  IFNB1/interferon-β-induced autophagy in MCF-7 breast cancer cells counteracts its proapoptotic function.

Authors:  Malene Ambjørn; Patrick Ejlerskov; Yawei Liu; Michael Lees; Marja Jäättelä; Shohreh Issazadeh-Navikas
Journal:  Autophagy       Date:  2013-03       Impact factor: 16.016

4.  Anti-tumor effect of adipose tissue derived-mesenchymal stem cells expressing interferon-β and treatment with cisplatin in a xenograft mouse model for canine melanoma.

Authors:  Jin ok Ahn; Hee woo Lee; Kyoung won Seo; Sung keun Kang; Jeong chan Ra; Hwa young Youn
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

Review 5.  Type I interferons: key players in normal skin and select cutaneous malignancies.

Authors:  Aimen Ismail; Nabiha Yusuf
Journal:  Dermatol Res Pract       Date:  2014-01-05

6.  Bispecific Antibodies for IFN-β Delivery to ErbB2+ Tumors.

Authors:  Vladislav S Rybchenko; Anna A Panina; Teimur K Aliev; Olga N Solopova; Dmitry S Balabashin; Valery N Novoseletsky; Dmitry A Dolgikh; Petr G Sveshnikov; Mikhail P Kirpichnikov
Journal:  Biomolecules       Date:  2021-12-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.